drugset / Trial / NCT05861310

Effectivity and Safety of Metronidazole 1% Cream in Rosacea Therapy

NCT05861310

RandomizedParallel-groupSingle-blindTreatment

Summary

Rosacea is a chronic inflammatory disease of the central facial region, which can also occur in the neck and chest regions. Microbes that play a role in rosacea are Demodex folliculorum and Helicobactor pylori. On the skin with rosacea have decreased skin barrier function. This clinical study will compare the effectiveness and safety of metronidazole 1% cream as the main therapy in rosacea patients. Participants who will become research subjects are women and men aged 18-60 years who meet the inclusion criteria. Research subjects were divided into 2 groups. The control group will use placebo cream (without the drug substance) and the comparison group will use metronidazole 1% cream.

Timeline

Start
2023-05
Primary completion
2023-07
Completion
2023-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Metronidazole Small molecule 1 % Topical

Indications